TDGF1 Antikörper (AA 1-50)

Produktnummer ABIN540265

Produktdetails anti-TDGF1 Antikörper

Target: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Bindungsspezifität: AA 1-50

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TDGF1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunocytochemistry (ICC)

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of Tdgf1.

Spezifität: This antibody is specific to cripto.

Kreuzreaktivität: Human, Maus

Produktmerkmale: Antibody Reactive Against Synthetic Peptide.

Immunogen: A synthetic peptide corresponding to amino acids 1-50 of mouse Tdgf1.

Anwendungsinformationen

Applikationshinweise: Flow Cytometry (1:100)
Immunocytochemistry (1:50-1:200)
Immunofluorescence (1:50-1:200)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In Tris-glycine, 150 mM NaCl

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4°C. Do not freeze.

Referenzen für anti-TDGF1 Antikörper (ABIN540265)

Xing, Hu, Pietersz, Hosick, McKenzie: "Cripto: a novel target for antibody-based cancer immunotherapy." in: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).

Adamson, Minchiotti, Salomon: "Cripto: a tumor growth factor and more." in: Journal of cellular physiology, Vol. 190, Issue 3, pp. 267-78, (2002) (PubMed).

Schiffer, Foley, Kaffashan, Hronowski, Zichittella, Yeo, Miatkowski, Adkins, Damon, Whitman, Salomon, Sanicola, Williams: "Fucosylation of Cripto is required for its ability to facilitate nodal signaling." in: The Journal of biological chemistry, Vol. 276, Issue 41, pp. 37769-78, (2001) (PubMed).

Details zu TDGF1

Target: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Andere Bezeichnung: TDGF1 / CRIPTO (TDGF1 Produkte)

Synonyme: CR antikoerper, CRGF antikoerper, CRIPTO antikoerper, CR1 antikoerper, cripto antikoerper, cb85 antikoerper, tdgf1 antikoerper, wu:fe01d04 antikoerper, zgc:109829 antikoerper, Cripto-1 antikoerper, cr1 antikoerper, cr1a antikoerper, frl-1 antikoerper, frl1 antikoerper, xcr1 antikoerper, TDGF1 antikoerper, tdgf3 antikoerper, cripto-3 antikoerper, teratocarcinoma-derived growth factor 1 antikoerper, teratocarcinoma-derived growth factor 1, member 3 L homeolog antikoerper, teratocarcinoma-derived growth factor 1, member 1 antikoerper, TDGF1 antikoerper, Tdgf1 antikoerper, tdgf1 antikoerper, tdgf1.3.L antikoerper, tdgf1.1 antikoerper

Gen-ID: 21667

Pathways: EGFR Signaling Pathway